新冠

• Pardes Biosciences and FS Development Corp. II Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Advancing Oral Antiviral Drugs to Treat and Prevent SARS-CoV-2 Infections 2021-12-28
• 瑞科生物完成10亿元C轮融资，加速重点疫苗国产替代进程 2021-06-12
• Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing 2021-05-25
• Resilience Receives USD $164 Million Investment from the Government of Canada to Modernize and Expand Its Ontario Biomanufacturing Site, Improving Pandemic Preparedness 2021-05-18
• 艾博生物宣布完成6亿元B轮融资，加速新冠疫苗研发、建设疫苗产业基地并进一步扩充产品管线 2021-04-07
• Immune Biosolutions Receives C$13.44 Million to Develop and Biomanufacture its Promising Immunotherapy to Treat COVID-19 and its Variants 2021-03-17
• TECH START-UP THERAVECTYS ANNOUNCES $20M FUNDING ROUND 2021-02-15
• Forbion invests USD 2.3M in seed financing of CoviCept Therapeutics, Inc. 2021-01-19
• Adeptrix Closes Series A Financing to Commercialize BAMS™ Bioanalytical Reagents for Life Science Research 2021-01-07
• Revelation Biosciences Inc. Announces $9.1 Million Common Stock and Series A Financing 2021-01-06

登录医药魔方官网 查看更多资讯